Hepatocellular carcinoma
Top Cited Papers
Open Access
- 1 December 2003
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 362 (9399), 1907-1917
- https://doi.org/10.1016/s0140-6736(03)14964-1
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalJournal of Hepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- A model to predict survival in patients with end-stage liver diseaseJournal of Hepatology, 2001
- Hepatobiliary surgeryJournal of Hepatology, 2000
- Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trialJournal of Hepatology, 1998
- No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosisJournal of Hepatology, 1995
- Controlled trial of tamoxifen in patients with advanced hepatocellular carcinomaJournal of Hepatology, 1994
- Sex hormone receptors in hepatocellular carcinoma: Is there a rationale for hormonal treatment?Journal of Hepatology, 1993
- A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaJournal of Hepatology, 1990
- Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary HemochromatosisThe New England Journal of Medicine, 1985